Successful treatment of steroid-refractory gastrointestinal acute graft-versus-host disease with adjuvant vedolizumab therapy in a pediatric allogeneic stem cell transplant recipient

被引：5
作者：
Pai, Vinita [1 ,2 ]
Abu-Arja, Rolla [3 ,4 ]
Auletta, Jeffery J. [3 ,4 ]
Rangarajan, Hemalatha G. [3 ,4 ]
机构：
[1] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[2] Nationwide Childrens Hosp, Pharm Dept, Columbus, OH USA
[3] Nationwide Childrens Hosp, Div Hematol Oncol Blood & Marrow Transplant, 700 Childrens Dr, Columbus, OH 43205 USA
[4] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷 / 08期
关键词：
D O I：
10.1002/pbc.28298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 10 条
  • [1] Lessons Learned from Early Experiences with Vedolizumab for Steroid-Refractory Acute Graft-versus-Host Disease with Gastrointestinal Involvement
    Bukauskas, Adomas
    Griskevicius, Laimonas
    Peceliunas, Valdas
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1597 - 1597
  • [2] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    [J]. BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [3] Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease
    Coltoff, Alexander
    Lancman, Guido
    Kim, Sara
    Steinberg, Amir
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 900 - 904
  • [4] Anti-a4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease
    Danylesko, Ivetta
    Bukauskas, Adomas
    Paulson, Martin
    Peceliunas, Valdas
    Gedde-Dahl, Tobias
    Shimoni, Avichai
    Shouval, Roni
    Griskevicius, Laimonas
    Floisand, Yngvar
    Nagler, Arnon
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 987 - 993
  • [5] Safety and Effectiveness of Vedolizumab in Patients with Steroid- Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
    Floisand, Yngvar
    Lazarevic, Vladimir Lj
    Maertens, Johan
    Mattsson, Jonas
    Shah, Nirav N.
    Zachee, Pierre
    Taylor, Aliki
    Akbari, Mona
    Quadri, Syed
    Parfionovas, Andrejus
    Chen, Yi-Bin
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 720 - 727
  • [6] Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
    Floisand, Yngvar
    Lundin, Knut E. A.
    Lazarevic, Vladimir
    Kristiansen, Jorn Dehli
    Osnes, Liv T. N.
    Tjonnfjord, Geir E.
    Reims, Henrik Mikael
    Gedde-Dahl, Tobias
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (01) : 172 - 175
  • [7] Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes
    Koliani-Pace, Jenna L.
    Singh, Siddharth
    Luo, Michelle
    Hirten, Robert
    Aniwan, Satimai
    Kochhar, Gursimran
    Chang, Shannon
    Lukin, Dana
    Gao, Youran
    Bohm, Matthew
    Swaminath, Arun
    Gupta, Nitin
    Shmidt, Eugenia
    Meserve, Joseph
    Winters, Adam
    Chablaney, Shreya
    Faleck, David M.
    Yang, Jiao
    Huang, Zhongwen
    Boland, Brigid S.
    Shashi, Preeti
    Weiss, Aaron
    Hudesman, David
    Varma, Sashidhar
    Fischer, Monika
    Sultan, Keith
    Shen, Bo
    Kane, Sunanda
    Loftus, Edward V., Jr.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Sandborn, William J.
    Lasch, Karen
    Siegel, Corey A.
    Dulai, Parambir S.
    [J]. INFLAMMATORY BOWEL DISEASES, 2019, 25 (11) : 1854 - 1861
  • [8] The α4β7 blockade with vedolizumab is effective in prevention of graft vs. host disease using a xenogeneic mouse model
    Palaniyandi, Senthilnathan
    Kumari, Reena
    Strattan, Ethan
    Huang, Timothy
    Du, Jing
    Hakim, Natalya
    Kesler, Melissa V.
    Hildebrandt, Gerhard C.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (02) : E39 - E41
  • [9] Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
    Schneider, Anna-Maria
    Weghuber, Daniel
    Hetzer, Benjamin
    Entenmann, Andreas
    Mueller, Thomas
    Zimmermann, Georg
    Schuetz, Sebastian
    Huber, Wolf-Dietrich
    Pichler, Judith
    [J]. BMC GASTROENTEROLOGY, 2018, 18
  • [10] Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease
    Singh, Namita
    Rabizadeh, Shervin
    Jossen, Jacqueline
    Pittman, Nanci
    Check, Morgan
    Hashemi, Ghonche
    Phan, Becky L.
    Hyams, Jeffrey S.
    Dubinsky, Marla C.
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (09) : 2121 - 2126
1